Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
10.3892/mmr.2015.4724 93 ZhaoT.ParikhP.BhashyamS.BolukogluH.PoornimaI.ShenY
GLP-1 Receptor Agonist Market Demand, Opportunity, 2026-2034 REPORT DETAILS GLP-1 Receptor Agonist Market Overview The global GLP-1 receptor agonist market size was valued at USD 61.89 billion in 2025
Spending on glucagonlike peptide1 receptor agonists, or GLP1s, in the United States increased over 500% from $13.7 billion in 2018 to $71.7 billion in 2023, according to the Journal of the American Heart Association, Although these medications were initially developed to treat Type 2 diabetes, newer indications now include weight management
GLP-1 treatments level the playing field
How does Semaglutide GLP-1 affect BMI
GLP-1R, together with four other glucagon receptors (GCGR, GLP-2R, GIPR, and GHRHR), belongs to the secretin (class B1) GPCR family, whose endogenous ligands are peptide hormones
